p.73 抽出テキスト

77. Zuin M, Roncon L, Passaro A, Bosi C, Cervellati C, Zuliani G. Risk of dementia in patients with atrial fibrillation: short versus long follow-up. A systematic review and meta-analysis. Int J Geriatr Psychiatry 2021;36:1488–500. https://doi.org/10.1002/gps. 5582 78. Mobley AR, Subramanian A, Champsi A, Wang X, Myles P, McGreavy P, et al. Thromboembolic events and vascular dementia in patients with atrial fibrillation and low apparent stroke risk. Nat Med 2024. https://doi.org/10.1038/s41591-024- 03049-9. 79. Wijtvliet E, Tieleman RG, van Gelder IC, Pluymaekers N, Rienstra M, Folkeringa RJ, et al. Nurse-led vs. usual-care for atrial fibrillation. Eur Heart J 2020;41:634–41. https://doi.org/10.1093/eurheartj/ehz666 80. Wong CX, Brooks AG, Lau DH, Leong DP, Sun MT, Sullivan T, et al. Factors associated with the epidemic of hospitalizations due to atrial fibrillation. Am J Cardiol 2012;110: 1496–9. https://doi.org/10.1016/j.amjcard.2012.07.011 81. Dai H, Zhang Q, Much AA, Maor E, Segev A, Beinart R, et al. Global, regional, and national prevalence, incidence, mortality, and risk factors for atrial fibrillation, 1990– 2017: results from the Global Burden of Disease Study 2017. Eur Heart J Qual Care Clin Outcomes 2021;7:574–82. https://doi.org/10.1093/ehjqcco/qcaa061 82. Țica O, Țica O, Bunting KV, deBono J, Gkoutos GV, Popescu MI, et al. Post-mortem examination of high mortality in patients with heart failure and atrial fibrillation. BMC Med 2022;20:331. https://doi.org/10.1186/s12916-022-02533-8 83. Bassand JP, Virdone S, Badoz M, Verheugt FWA, Camm AJ, Cools F, et al. Bleeding and related mortality with NOACs and VKAs in newly diagnosed atrial fibrillation: results from the GARFIELD-AF registry. Blood Adv 2021;5:1081–91. https://doi.org/10.1182/ bloodadvances.2020003560 84. Pokorney SD, Piccini JP, Stevens SR, Patel MR, Pieper KS, Halperin JL, et al. Cause of death and predictors of all-cause mortality in anticoagulated patients with nonvalvular atrial fibrillation: data from ROCKET AF. J Am Heart Assoc 2016;5:e002197. https://doi. org/10.1161/JAHA.115.002197 85. Granada J, Uribe W, Chyou PH, Maassen K, Vierkant R, Smith PN, et al. Incidence and predictors of atrial flutter in the general population. J Am Coll Cardiol 2000;36:2242–6. https://doi.org/10.1016/S0735-1097(00)00982-7 86. Vadmann H, Nielsen PB, Hjortshoj SP, Riahi S, Rasmussen LH, Lip GY, et al. Atrial flutter and thromboembolic risk: a systematic review. Heart 2015;101:1446–55. https:// doi.org/10.1136/heartjnl-2015-307550 87. Lelorier P, Humphries KH, Krahn A, Connolly SJ, Talajic M, Green M, et al. Prognostic differences between atrial fibrillation and atrial flutter. Am J Cardiol 2004;93:647–9. https://doi.org/10.1016/j.amjcard.2003.11.042 88. Biblo LA, Yuan Z, Quan KJ, Mackall JA, Rimm AA. Risk of stroke in patients with atrial flutter. Am J Cardiol 2001;87:346–9, A9. https://doi.org/10.1016/S0002-9149(00) 01374-6 89. Corrado G, Sgalambro A, Mantero A, Gentile F, Gasparini M, Bufalino R, et al. Thromboembolic risk in atrial flutter. The FLASIEC (FLutter Atriale Società Italiana di Ecografia Cardiovascolare) multicentre study. Eur Heart J 2001;22:1042–51. https://doi.org/10.1053/euhj.2000.2427 90. Lin YS, Chen TH, Chi CC, Lin MS, Tung TH, Liu CH, et al. Different implications of heart failure, ischemic stroke, and mortality between nonvalvular atrial fibrillation and atrial flutter–a view from a national cohort study. J Am Heart Assoc 2017;6: e006406. https://doi.org/10.1161/JAHA.117.006406 91. Giehm-Reese M, Johansen MN, Kronborg MB, Jensen HK, Gerdes C, Kristensen J, et al. Discontinuation of oral anticoagulation and risk of stroke and death after ablation for typical atrial flutter: a nation-wide Danish cohort study. Int J Cardiol 2021;333:110–6. https://doi.org/10.1016/j.ijcard.2021.02.057 92. Gallagher C, Rowett D, Nyfort-Hansen K, Simmons S, Brooks AG, Moss JR, et al. Patient-centered educational resources for atrial fibrillation. JACC Clin Electrophysiol 2019;5:1101–14. https://doi.org/10.1016/j.jacep.2019.08.007 93. Chung MK, Fagerlin A, Wang PJ, Ajayi TB, Allen LA, Baykaner T, et al. Shared decision making in cardiac electrophysiology procedures and arrhythmia management. Circ Arrhythm Electrophysiol 2021;14:e007958. https://doi.org/10.1161/CIRCEP.121. 007958 94. Wang PJ, Lu Y, Mahaffey KW, Lin A, Morin DP, Sears SF, et al. A randomized clinical trial to evaluate an atrial fibrillation stroke prevention shared decision-making pathway. J Am Heart Assoc 2022;12:e028562. https://doi.org/10.1161/JAHA.122.028562 95. Seaburg L, Hess EP, Coylewright M, Ting HH, McLeod CJ, Montori VM. Shared decision making in atrial fibrillation: where we are and where we should be going. Circulation 2014;129:704–10. https://doi.org/10.1161/CIRCULATIONAHA.113. 004498 96. Zhang J, Lenarczyk R, Marin F, Malaczynska-Rajpold K, Kosiuk J, Doehner W, et al. The interpretation of CHA2DS2-VASc score components in clinical practice: a joint survey by the European Heart Rhythm Association (EHRA) scientific initiatives committee, the EHRA young electrophysiologists, the Association of Cardiovascular Nursing and Allied Professionals, and the European Society of Cardiology council on stroke. Europace 2021;23:314–22. https://doi.org/10.1093/europace/euaa358 97. Omoush A, Aloush S, Albashtawy M, Rayan A, Alkhawaldeh A, Eshah N, et al. Nurses’ knowledge of anticoagulation therapy for atrial fibrillation patients: effectiveness of an educational course. Nurs Forum 2022;57:825–32. https://doi.org/10.1111/nuf.12770 98. Heidbuchel H, Dagres N, Antz M, Kuck KH, Lazure P, Murray S, et al. Major knowledge gaps and system barriers to guideline implementation among European physicians treating patients with atrial fibrillation: a European Society of Cardiology international educational needs assessment. Europace 2018;20:1919–28. https://doi.org/10.1093/ europace/euy039 99. Bunting KV, Van Gelder IC, Kotecha D. STEEER-AF: a cluster-randomized education trial from the ESC. Eur Heart J 2020;41:1952–4. https://doi.org/10.1093/eurheartj/ ehaa421 100. Tanner FC, Brooks N, Fox KF, Gonçalves L, Kearney P, Michalis L, et al. ESC core curriculum for the cardiologist. Eur Heart J 2020;41:3605–92. https://doi.org/10.1093/ eurheartj/ehaa641 101. Astin F, Carroll D, De Geest S, Fernandez-Oliver AL, Holt J, Hinterbuchner L, et al. A core curriculum for the continuing professional development of nurses working in cardiovascular settings: developed by the education committee of the Council on Cardiovascular Nursing and Allied Professions (CCNAP) on behalf of the European Society of Cardiology. Eur J Cardiovasc Nurs 2015;14:S1–17. https://doi.org/10.1177/ 1474515115580905 102. Sterlinski M, Bunting KV, Boriani G, Boveda S, Guasch E, Mont L, et al. STEEER-AF Trial Team. Design and deployment of the STEEER-AF trial to evaluate and improve guideline adherence: a cluster-randomised trial by the European Society of Cardiology and European Heart Rhythm Association. Europace 2024:euae178. https://doi.org/ 10.1093/europace/euae178 103. Vinereanu D, Lopes RD, Bahit MC, Xavier D, Jiang J, Al-Khalidi HR, et al. A multifaceted intervention to improve treatment with oral anticoagulants in atrial fibrillation (IMPACT-AF): an international, cluster-randomised trial. Lancet 2017;390:1737–46. https://doi.org/10.1016/S0140-6736(17)32165-7 104. Franchi C, Antoniazzi S, Ardoino I, Proietti M, Marcucci M, Santalucia P, et al. Simulation-based education for physicians to increase oral anticoagulants in hospitalized elderly patients with atrial fibrillation. Am J Med 2019;132:e634–47. https://doi. org/10.1016/j.amjmed.2019.03.052 105. Baicus C, Delcea C, Dima A, Oprisan E, Jurcut C, Dan GA. Influence of decision aids on oral anticoagulant prescribing among physicians: a randomised trial. Eur J Clin Invest 2017;47:649–58. https://doi.org/10.1111/eci.12786 106. Ono F, Akiyama S, Suzuki A, Ikeda Y, Takahashi A, Matsuoka H, et al. Impact of care coordination on oral anticoagulant therapy among patients with atrial fibrillation in routine clinical practice in Japan: a prospective, observational study. BMC Cardiovasc Disord 2019;19:235. https://doi.org/10.1186/s12872-019-1216-y 107. Ferguson C, Hickman LD, Phillips J, Newton PJ, Inglis SC, Lam L, et al. An mHealth intervention to improve nurses’ atrial fibrillation and anticoagulation knowledge and practice: the EVICOAG study. Eur J Cardiovasc Nurs 2019;18:7–15. https://doi.org/ 10.1177/1474515118793051 108. Lip GY, Laroche C, Popescu MI, Rasmussen LH, Vitali-Serdoz L, Dan GA, et al. Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF general pilot registry. Europace 2015;17:1777–86. https://doi.org/10.1093/ europace/euv269 109. Linde C, Bongiorni MG, Birgersdotter-Green U, Curtis AB, Deisenhofer I, Furokawa T, et al. Sex differences in cardiac arrhythmia: a consensus document of the European Heart Rhythm Association, endorsed by the Heart Rhythm Society and Asia Pacific Heart Rhythm Society. Europace 2018;20:1565–1565ao. https://doi.org/10.1093/ europace/euy067 110. Camm AJ, Accetta G, Al Mahmeed W, Ambrosio G, Goldhaber SZ, Haas S, et al. Impact of gender on event rates at 1 year in patients with newly diagnosed non-valvular atrial fibrillation: contemporary perspective from the GARFIELD-AF registry. BMJ Open 2017;7:e014579. https://doi.org/10.1136/bmjopen-2016-014579 111. Emdin CA, Wong CX, Hsiao AJ, Altman DG, Peters SA, Woodward M, et al. Atrial fibrillation as risk factor for cardiovascular disease and death in women compared with men: systematic review and meta-analysis of cohort studies. BMJ 2016;532: h7013. https://doi.org/10.1136/bmj.h7013 112. Tomasdottir M, Friberg L, Hijazi Z, Lindback J, Oldgren J. Risk of ischemic stroke and utility of CHA2 DS2 -VASc score in women and men with atrial fibrillation. Clin Cardiol 2019;42:1003–9. https://doi.org/10.1002/clc.23257 113. Kloosterman M, Chua W, Fabritz L, Al-Khalidi HR, Schotten U, Nielsen JC, et al. Sex differences in catheter ablation of atrial fibrillation: results from AXAFA-AFNET 5. Europace 2020;22:1026–35. https://doi.org/10.1093/europace/euaa015 114. Benjamin EJ, Thomas KL, Go AS, Desvigne-Nickens P, Albert CM, Alonso A, et al. Transforming atrial fibrillation research to integrate social determinants of health: a national heart, lung, and blood institute workshop report. JAMA Cardiol 2023;8:182–91. https://doi.org/10.1001/jamacardio.2022.4091 115. Karlsson LO, Nilsson S, Bang M, Nilsson L, Charitakis E, Janzon M. A clinical decision support tool for improving adherence to guidelines on anticoagulant therapy in patients with atrial fibrillation at risk of stroke: a cluster-randomized trial in a Swedish primary care setting (the CDS-AF study). PLoS Med 2018;15:e1002528. https://doi. org/10.1371/journal.pmed.1002528 Downloaded from academic.oup.com/eurheartj/article/45/36/3314/7738779 by guest on 07 October 2026